Navigation Links
FDA Approves LIVALO(R) for Primary Hypercholesterolemia and Combined Dyslipidemia
Date:8/3/2009

ated level of cholesterol in the blood is called hypercholesterolemia, commonly referred to as high cholesterol.

Dyslipidemia is well established as one of the strongest independent predictors of cardiovascular morbidity and mortality. Despite the availability of treatments in the U.S., there is still a need for better control of and treatment for dyslipidemia. According to the American Heart Association, approximately one out of every three American adults has an LDL cholesterol level of 130mg/dL or higher, which is a major risk factor for coronary heart disease (CHD) and stroke. In addition, less than half of patients who qualify for any kind of lipid-modifying treatment( )for CHD risk reduction are receiving it, and only about( )one-third of patients who are on treatment are achieving their LDL( )goals.

About Kowa Company Ltd., Kowa Pharmaceuticals America, Inc. and Kowa Research Institute, Inc.

Kowa Company, Ltd. (KCL) is a privately held multinational company headquartered in Nagoya, Japan. Established in 1894, KCL is actively engaged in various manufacturing and commercial activities in the fields of pharmaceutical, life science, information technology, textiles, machinery and various consumer products. KCL's pharmaceutical division is focused on cardiovascular therapeutics, with sales of the company's flagship product, LIVALO(R) (pitavastatin), totaling $340 million (12% market share) in Japan during the 2008 fiscal year and expected to exceed $500 million in the near future.

Kowa Pharmaceuticals America, Inc. (KPA) is a specialty pharmaceutical company focused primarily in the area of cardiometabolic therapeutic area. The company, started in 2001 as ProEthic Pharmaceuticals, Inc., was acquired by KCL in September of 2008. A privately held company, KPA focuses its efforts on the acquisition, development, licensing and marketing of pharmaceutical products. Its le
'/>"/>

SOURCE Kowa Pharmaceuticals America, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
2. House Committee Approves Amendment Eliminating Cost-Sharing for Medicaid Preventive Services
3. FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension
4. FDA Approves Sculptra(R)Aesthetic, a Facial Injectable for Correction of Nasolabial Folds and Other Facial Wrinkles
5. Kaiser Permanente Approves $11 Million in Community Benefit Grants
6. FDA Approves Expanded Use of Lillys FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis
7. American Academy of Orthopaedic Surgeons approves new guideline for the treatment of pediatric diaphyseal femur fractures
8. American Academy of Orthopaedic Surgeons Approves New Guideline for the Treatment of Pediatric Diaphyseal Femur Fractures
9. FDA Approves VITROS(R) Anti-HCV Assay for Use On VITROS 5600(R) Integrated and VITROS 3600(R) Immunodiagnostic Systems
10. FDA Approves Seasonal Flu Vaccine for 2009-2010
11. FDA Approves Boston Scientifics TAXUS(R) Liberte(R) Long Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014) - New research published today in the ... cases could reach 6,800 in West Africa by the ... not enacted. , Arizona State University and Harvard ... rate of rise in cases significantly increased in August ... mass quarantine was put in place, indicating that the ...
(Date:9/19/2014)... Recent two-generation approaches to reducing poverty that help ... from researchers, advocates, and foundations. By combining education ... move to jobs that offer a path out ... for children, these programs aim to improve the ... a new report from the National Center for ...
(Date:9/19/2014)... Famous Vancouver company, Pro Ace Heating ... now become a one-stop-solution for heating, air conditioning, plumbing ... The company has achieved this status by providing a ... While there are many companies that provide these services ... vendor who can offer all of these services together ...
(Date:9/19/2014)... 2014 (HealthDay News) -- When it comes to firearm ... United States, while the District of Columbia has the ... decade, deaths from gun-related violence -- including murders, suicides ... States, the study revealed. Hawaii,s rate was roughly three ... spectrum, the District of Columbia had the highest rate ...
(Date:9/19/2014)... September 19, 2014 Recently, Top10BestSEOHosting.com ... announced that JustHost, IX Web Hosting and Bluehost ... , “As is known to most people, VPS ... a physical server computer into many servers, each ... running on someone’s own dedicated computer,” the manager ...
Breaking Medicine News(10 mins):Health News:Research predicts possible 6,800 new Ebola cases this month 2Health News:A two generation lens: Current state policies fail to support families with young children 2Health News:Pro Ace Now Provides Heating, Air Conditioning, Plumbing & Electrical Services under One Roof 2Health News:U.S. Gun Deaths Lowest in Hawaii, Highest in D.C. 2Health News:Top10BestSEOHosting.com: JustHost is One of the Best VPS Suppliers in 2014 2
... show injury in as little as 6 days , , ... drug Tysabri can start causing liver damage within six days ... In January, the U.S. Food and Drug Administration expanded the ... of the digestive tract. , The drug has also been ...
... in a severe form of the disorder, , , WEDNESDAY, Feb. 27 ... and a more severe form of the disease caused by one ... are the two main findings from a Massachusetts study that found ... 35 babies a year before 2003 to less than 20 babies ...
... net premiums written increase 22% over the ... comparable year-earlier quarterly results, FARMINGTON, Conn., Feb. 27 ... today announced its financial results for the fourth quarter ended,December ... http://www.newscom.com/cgi-bin/prnh/20060829/NETU014LOGO ), -- Gross premiums written for ...
... (Nasdaq: ACUR ) announced that President and Chief,Executive ... for health,reasons for an as-yet undetermined period. Mr. Reddick ... Board of Directors. At the same time,the Company announced ... Chairman of the Board. Mr. Markham has been a ...
... Targeted Synergies Sells Rights to Bystolic(TM) (Nebivolol) for $370 ... To Consider a Sale of Dey ... MYL ),today announced its financial results for the three and nine ... for the Merck,Generics acquisition, and announced a number of strategic and ...
... 2008 Nektar,Therapeutics (Nasdaq: NKTR ) announced today ... ended December 31, 2007., Revenue totaled $65.8 million ... in the fourth quarter of 2006. For the year ... million compared to,$217.7 million in 2006., Cash, cash ...
Cached Medicine News:Health News:Tysabri May Cause Liver Damage, Health Officials Say 2Health News:Newborn Screening Suggests Decline in Cystic Fibrosis 2Health News:Newborn Screening Suggests Decline in Cystic Fibrosis 3Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 2Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 3Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 4Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 5Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 6Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 7Health News:Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board 2Health News:Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board 3Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 2Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 3Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 4Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 5Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 6Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 7Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 8Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 9Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 10Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 11Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 12Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 13Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 14Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 15Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 2Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 3Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 4Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 5Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 6Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 7Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 8Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 9
(Date:9/19/2014)... BETHESDA, Md. , Sept. 19, 2014 ... an initiative to harmonize global post-approval changes protocols. ... level of interest in the topic expressed by industry participants ... workshop, held earlier this month in Washington, ... and EMA were on hand for the workshop. Attendees ...
(Date:9/19/2014)... Sept. 19, 2014 Kiromic, LLC, a ... Kent Hance , the former chancellor of Texas Tech ... as chancellor in July 2014, after raising $1.2 billion for ... Kent Hance , the most successful chancellor in the ... not only as an investor, but also as our new ...
(Date:9/19/2014)... Research and Markets has announced the addition of ... Mental Disorder) Market - Forecast to 2023" report to ... the human microbiome market is segmented by application, disease, product, ... to be valued as $294 million in 2019 and is ... forecast period of 2019-2023. The market is driven by growing ...
Breaking Medicine Technology:PDA Launches Effort to Harmonize Global Post-Approval Changes Protocols 2Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 2Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 2Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 3
... ALISO VIEJO, Calif., Nov. 9 Clarient, Inc. (Nasdaq: ... oncologists and the pharmaceutical industry, today announced that it is ... New York City. , The first presentation will be made ... 1:40 pm EST on Tuesday, November 17. The conference will ...
... Care Reform Bill , Critical legislation would strengthen ... Nov. 7 Today the United States House ... strengthen Medicare for seniors and end discrimination by insurance companies ... , The Affordable Health Care for America Act ...
Cached Medicine Technology:Clarient to Present at Upcoming Healthcare Investor Conferences in New York City 2AARP Idaho Key Vote News Alert 2AARP Idaho Key Vote News Alert 3
Viscoelastic Cannula, 23 g. Angled. 7 mm angled tip cannula with unique hub that facilitates flow of viscoelastic material. Overall length 23 mm. 5/box....
Anterior Chamber Needle, 27 g. Angled. 5 mm angled tip. Overall length 20 mm. 5/box....
Nucleus Hydrodissection Cannula, 25 g. Angled with flattened tip. 7 mm angled shaft with flattened tip for insertion under the capsular flap. Overall length 19 mm. 5/box....
Hydrodissection / Aspiration Cannula, 25 g. Angled with left hook. 10 mm angled shaft with 2.5 mm left hook tip. Overall length 20 mm. 5/box....
Medicine Products: